Altman Z-Score

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

Atlanticus Holdings Corp. confirms its quarterly preferred stock dividend, highlighting a rare blend of FinTech innovation with reliable investor returns.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Powersports giant Massimo Group's stock plummets after announcing a bold but risky plan to acquire an AI firm and enter the health robotics market.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

Cabot Corp's purchase of a key Bridgestone facility in Mexico is a strategic play to dominate the reinforcing carbons market and secure vital supply chains.

The oil & gas operator is one step from a NYSE listing, promising a 13.5% dividend yield and a major consolidation play in the mature assets market.

A new initiative from the Center for Educational Innovation aims to tackle the workforce readiness gap with AI, robotics, and teacher leadership training.

Onity Group is raising $150 million via high-yield notes, a strategic but risky move to refinance debt and fund growth amid a complex financial backdrop.

Facing a Nasdaq delisting threat, K Wave Media bets on a risky mix of K-content IP and a massive Bitcoin treasury to save its $50M valuation.